The dependence of MYC-driven cancers on components of the spliceosome and the presence of splicing abnormalities in MYC-driven neuroblastoma raise the possibility that splicing factors could be effective targets in neuroblastoma. The gene discussed is MYC; the disease is neuroblastoma.